Microbes vs. Pharma
The discussion highlights the disconnect between the pharmaceutical industry and the understanding of microbes, emphasizing that many companies are entrenched in traditional chemical solutions. Despite the potential for significant profits in microbial research, the current regulatory landscape stifles innovation. There's a call for a shift in mindset within pharma to embrace the benefits of microbes in disease prevention, suggesting that change is not just possible but inevitable.In this clip
From this podcast
Rich Roll
PROBIOTICS EXPERT: Using Microbes To PROTECT Your Health (& HEAL The Planet) | Dr. Gregor Reid
Related Questions
Why are pharmaceuticals so expensive in the episode 222: Matt McCarthy | The Race to Stop a Superbug Epidemic and the clip Superbugs and Antibiotics?
What do you think about the pharmaceutical industry in relation to the episode 222: Matt McCarthy | The Race to Stop a Superbug Epidemic and the clip Antibiotic Market Solutions?
Can we fix Pharma's role in healthcare as discussed in the episode 222: Matt McCarthy | The Race to Stop a Superbug Epidemic and the clip Antibiotic Market Solutions?